IL145127A0 - Pharmaceutical composition based on polyaromatic compounds - Google Patents
Pharmaceutical composition based on polyaromatic compoundsInfo
- Publication number
- IL145127A0 IL145127A0 IL14512700A IL14512700A IL145127A0 IL 145127 A0 IL145127 A0 IL 145127A0 IL 14512700 A IL14512700 A IL 14512700A IL 14512700 A IL14512700 A IL 14512700A IL 145127 A0 IL145127 A0 IL 145127A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- composition based
- polyaromatic compounds
- polyaromatic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9903390A FR2790954B1 (fr) | 1999-03-18 | 1999-03-18 | Composition pharmaceutique a base de composes polyaromatiques |
| PCT/FR2000/000672 WO2000055160A1 (fr) | 1999-03-18 | 2000-03-17 | Composition pharmaceutique a base de composes polyaromatiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL145127A0 true IL145127A0 (en) | 2002-06-30 |
Family
ID=9543359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14512700A IL145127A0 (en) | 1999-03-18 | 2000-03-17 | Pharmaceutical composition based on polyaromatic compounds |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6583150B1 (xx) |
| EP (1) | EP1161432A1 (xx) |
| JP (1) | JP2002539212A (xx) |
| KR (1) | KR20020001778A (xx) |
| CN (1) | CN1344269A (xx) |
| AU (1) | AU778375B2 (xx) |
| BR (1) | BR0009113A (xx) |
| CA (1) | CA2361810A1 (xx) |
| CZ (1) | CZ20013348A3 (xx) |
| FR (1) | FR2790954B1 (xx) |
| HU (1) | HUP0200408A3 (xx) |
| IL (1) | IL145127A0 (xx) |
| NO (1) | NO20014450L (xx) |
| NZ (1) | NZ513853A (xx) |
| PL (1) | PL350899A1 (xx) |
| SK (1) | SK12282001A3 (xx) |
| WO (1) | WO2000055160A1 (xx) |
| ZA (1) | ZA200107074B (xx) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2797443B1 (fr) * | 1999-08-13 | 2003-10-31 | Lafon Labor | Procede de prepartion de quinoleine-5,8-diones |
| WO2017059401A2 (en) * | 2015-10-01 | 2017-04-06 | Duke University | Androgen receptor ligands |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB695752A (en) | 1950-06-15 | 1953-08-19 | Borg Warner | Improvements in or relating to rotary pumps and bushings for rotary pumps |
| US5182287A (en) * | 1989-11-03 | 1993-01-26 | Harbor Branch Oceanographic | Bioactive heterocycle alkaloids and methods of use |
| ES2088822B1 (es) * | 1994-02-24 | 1997-08-01 | Univ Madrid Complutense | Nuevos derivados antraquinonicos con actividad antitumoral y sus aplicaciones. |
| GB9708751D0 (en) * | 1997-04-29 | 1997-06-25 | Univ Madrid Complutense | New cytotoxic analogues of marine natural products derivatives of the pyrido (2,3,4-K1) acridine ring systems |
| GB9810998D0 (en) | 1998-05-21 | 1998-07-22 | Univ Madrid Complutense | Antitumour 1,5-diazaanthraquinones |
-
1999
- 1999-03-18 FR FR9903390A patent/FR2790954B1/fr not_active Expired - Fee Related
-
2000
- 2000-03-17 HU HU0200408A patent/HUP0200408A3/hu unknown
- 2000-03-17 US US09/936,842 patent/US6583150B1/en not_active Expired - Fee Related
- 2000-03-17 AU AU34374/00A patent/AU778375B2/en not_active Ceased
- 2000-03-17 IL IL14512700A patent/IL145127A0/xx unknown
- 2000-03-17 SK SK1228-2001A patent/SK12282001A3/sk unknown
- 2000-03-17 CN CN00805193A patent/CN1344269A/zh active Pending
- 2000-03-17 CA CA002361810A patent/CA2361810A1/fr not_active Abandoned
- 2000-03-17 PL PL00350899A patent/PL350899A1/xx not_active Application Discontinuation
- 2000-03-17 NZ NZ513853A patent/NZ513853A/en unknown
- 2000-03-17 CZ CZ20013348A patent/CZ20013348A3/cs unknown
- 2000-03-17 JP JP2000605589A patent/JP2002539212A/ja active Pending
- 2000-03-17 WO PCT/FR2000/000672 patent/WO2000055160A1/fr not_active Application Discontinuation
- 2000-03-17 BR BR0009113-8A patent/BR0009113A/pt not_active IP Right Cessation
- 2000-03-17 EP EP00912716A patent/EP1161432A1/fr not_active Withdrawn
- 2000-03-17 KR KR1020017011824A patent/KR20020001778A/ko not_active Application Discontinuation
-
2001
- 2001-08-27 ZA ZA200107074A patent/ZA200107074B/xx unknown
- 2001-09-13 NO NO20014450A patent/NO20014450L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20013348A3 (cs) | 2002-05-15 |
| FR2790954B1 (fr) | 2003-08-08 |
| AU778375B2 (en) | 2004-12-02 |
| ZA200107074B (en) | 2002-08-27 |
| KR20020001778A (ko) | 2002-01-09 |
| FR2790954A1 (fr) | 2000-09-22 |
| CN1344269A (zh) | 2002-04-10 |
| JP2002539212A (ja) | 2002-11-19 |
| HUP0200408A2 (hu) | 2002-07-29 |
| BR0009113A (pt) | 2001-12-18 |
| EP1161432A1 (fr) | 2001-12-12 |
| NO20014450D0 (no) | 2001-09-13 |
| PL350899A1 (en) | 2003-02-10 |
| AU3437400A (en) | 2000-10-04 |
| SK12282001A3 (sk) | 2002-08-06 |
| HUP0200408A3 (en) | 2003-03-28 |
| NZ513853A (en) | 2001-09-28 |
| CA2361810A1 (fr) | 2000-09-21 |
| WO2000055160A1 (fr) | 2000-09-21 |
| US6583150B1 (en) | 2003-06-24 |
| NO20014450L (no) | 2001-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL351387A1 (en) | Pharmaceutical composition | |
| HUP0202513A3 (en) | Betha-carboline pharmaceutical compositions | |
| GB0028088D0 (en) | Pharmaceutical compositions | |
| GB0001662D0 (en) | Pharmaceutical compositions | |
| PT1466615E (pt) | Composição farmacêutica | |
| GB9923436D0 (en) | Pharmaceutical compositions | |
| PL343769A1 (en) | Pharmaceutical composition | |
| ZA200000857B (en) | Pharmaceutical composition. | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| GB9818591D0 (en) | Pharmaceutical composition | |
| IL145632A0 (en) | Pharmaceutical compounds | |
| GB9904163D0 (en) | Pharmaceutical compositions | |
| GB9916434D0 (en) | Pharmaceutical compounds | |
| GB9911017D0 (en) | Pharmaceutical compositions | |
| GB9914255D0 (en) | Pharmaceutical compounds | |
| GB9903784D0 (en) | Pharmaceutical compounds | |
| HK1044117B (zh) | 藥物組合物 | |
| GB9904911D0 (en) | Pharmaceutical compositions | |
| GB9909154D0 (en) | Pharmaceutical formulation | |
| GB2373499B (en) | Pharmaceutical compounds | |
| IL145127A0 (en) | Pharmaceutical composition based on polyaromatic compounds | |
| GB9902651D0 (en) | Pharmaceutical compositions | |
| HU9800078D0 (en) | Pharmaceutical composition | |
| GB9916413D0 (en) | Pharmaceutical composition | |
| GB9916210D0 (en) | Pharmaceutical composition |